journal article·2020-01-01Open access

A systematic review and meta-analysis of long noncoding RNA linc-UBC1 expression and prognosis and clinicopathological phenotypes in human cancers

Xiewu Zhang, Haibiao Xie, Manjun Luo, Daqiang Liang, Weihua Lao, Weijun Ma, Yankun Lin

Abstract

According to previous studies, linc-UBC1 is abnormally expressed in various human tumours. Nonetheless, the clinical significance and mechanism of linc-UBC1 in cancer remains unclear. In our present analysis, we wanted to explore the specific role of linc-UBC1 in malignant tumours by integrating all of the relevant literature and subsequently elucidating the relationship between linc-UBC1 expression level and clinical characteristics of cancers. An elaborate database search of PubMed, Embase, Wanfang Data, Web of Science, Ovid, Medline, Cochrane Library and PMC was carried out up to 8 August 2019. We further applied the pooled odds ratio (OR) and hazard ratio (HR) to evaluate OS. After filtering by strict criteria, 11 studies containing 1017 cases were included in this analysis. Our results implied that high expression of linc-UBC1 was obviously related to poor OS in cancer (HR =1.735, 95% 1.348–2.235, p < .001 random effects model). Analogously, the data revealed that high expression of linc-UBC1 was highly correlated with lymph node metastasis (OR = 2.912, 95% CI: 2.056–4.125, p < .001 fix effects model) and high tumour stage (OR = 2.678, 95% CI: 1.859–3.857, p < .001 fix effects model). In summary, linc-UBC1 overexpression is associated with poor OS and advanced tumour stage and could be used as a novel prognostic biomarker in various cancers.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Cancer-related molecular mechanisms research · RNA modifications and cancer · RNA Research and Splicing

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pediatric Urology, Guangdong Women and Children Hospital

Department of Urology, Peking University First Hospital

Department of Ultrasonic, Guangdong Provincial Hospital of Traditional Chinese Medicine

Department of Sports Medicine, The First Hospital Affiliated to Shenzhen University, Second People’s Hospital

Funding

National Natural Science Foundation of China · Medicine Science Study Foundation of Guangdong Province

References (34)

Show source-provided references
1. 10.3322/caac.2149210.3322/caac.21492 ↗
2. 10.3322/caac.2133810.3322/caac.21338 ↗
3. 10.3322/caac.2133210.3322/caac.21332 ↗
4. 10.1016/j.cell.2006.11.00110.1016/j.cell.2006.11.001 ↗
5. 10.1016/S1470-2045(17)30438-210.1016/S1470-2045(17)30438-2 ↗
6. 10.1200/JCO.2007.15.171210.1200/JCO.2007.15.1712 ↗
7. 10.1016/j.ccr.2013.09.00710.1016/j.ccr.2013.09.007 ↗
8. 10.1136/bmj.h183210.1136/bmj.h1832 ↗
9. 10.1172/JCI8442110.1172/JCI84421 ↗
10. 10.1016/j.cell.2013.02.01210.1016/j.cell.2013.02.012 ↗
11. 10.1016/j.bbadis.2013.05.01010.1016/j.bbadis.2013.05.010 ↗
12. 10.1186/s12943-017-0728-210.1186/s12943-017-0728-2 ↗
13. 10.1089/dna.2017.385410.1089/dna.2017.3854 ↗
14. 10.1038/cddis.2017.8310.1038/cddis.2017.83 ↗
15. 10.1186/s12935-018-0544-910.1186/s12935-018-0544-9 ↗
16. Wang CH, Li YH, Tian HL, et al. Long non-coding RNA BLACAT1 promotes cell proliferation, migration and invasion in cervical cancer through activation of Wnt/β-catenin signaling pathway. Eur Rev Med Pharmacol Sci. 2018;22(10):3002–3009.
17. 10.1016/j.yexmp.2018.11.01010.1016/j.yexmp.2018.11.010 ↗
18. 10.2147/OTT.S12934310.2147/OTT.S129343 ↗
19. 10.1016/j.biopha.2018.01.13010.1016/j.biopha.2018.01.130 ↗
20. Niu G, Zhuang H, Li B, et al. Long noncoding RNA linc-UBC1 promotes tumor invasion and metastasis by regulating EZH2 and repressing E-cadherin in esophageal squamous cell carcinoma. J Buon. 2018;23:157–162.
21. 10.1371/journal.pone.017628710.1371/journal.pone.0176287 ↗
22. 10.1186/s12920-018-0413-310.1186/s12920-018-0413-3 ↗
23. Huang F-X, Chen H-J, Zheng F-X, et al. LncRNA BLACAT1 is involved in chemoresistance of non-small cell lung cancer cells by regulating autophagy. Int J Oncol. 2019;54(1):339–347.
24. 10.1186/1745-6215-8-1610.1186/1745-6215-8-16 ↗
25. 10.1136/bmj.327.7414.55710.1136/bmj.327.7414.557 ↗
26. 10.1111/jebm.1214110.1111/jebm.12141 ↗
27. Gao J, Cao R, Mu H. Long non-coding RNA UCA1 may be a novel diagnostic and predictive biomarker in plasma for early gastric cancer. Int J Clin Exp Path. 2015;8:12936–12942.
28. 10.1007/s00432-015-1980-810.1007/s00432-015-1980-8 ↗
29. 10.1016/j.cca.2018.07.00310.1016/j.cca.2018.07.003 ↗
30. 10.23736/S0026-4806.17.05100-X10.23736/S0026-4806.17.05100-X ↗
31. Song W, Wang K, Zhang R, et al. Long noncoding RNA MALAT1: a potential novel prognostic biomarkers in cancers based on meta-analysis. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2016;41:1163–1167.
32. 10.1016/j.cell.2018.01.01110.1016/j.cell.2018.01.011 ↗
33. 10.1002/2211-5463.1239710.1002/2211-5463.12397 ↗
34. 10.1038/srep4657210.1038/srep46572 ↗